论文部分内容阅读
目的分析头孢哌酮钠舒巴坦钠的临床应用效果。方法 147例需要抗感染患者,根据治疗方案不同分为对照组(66例,给予头孢他啶治疗)与研究组(81例,给予头孢哌酮钠舒巴坦钠治疗)。对比两组疗效及不良反应。结果研究组治疗总有效率(96.30%)高于对照组(71.21%),不良反应发生率(22.22%)高于对照组(6.06%),差异均具有统计学意义(P<0.05)。结论头孢哌酮钠舒巴坦钠的临床应用效果显著,但不良反应发生率高,应于临床中正确使用。
Objective To analyze the clinical effect of cefoperazone sodium and sulbactam sodium. Methods A total of 147 patients with anti-infectives were divided into control group (66 patients treated with ceftazidime) and study group (81 patients treated with cefoperazone sodium and sulbactam sodium) according to the treatment plan. Compare two groups of curative effect and adverse reaction. Results The total effective rate (96.30%) in the study group was higher than that in the control group (71.21%), the incidence of adverse reactions was higher (22.22%) than that in the control group (6.06%), the difference was statistically significant (P <0.05). Conclusion Cefoperazone sodium and sulbactam sodium clinical effect is significant, but the incidence of adverse reactions, should be used correctly in clinical practice.